166 related articles for article (PubMed ID: 16055131)
1. Asymmetric dimethylarginine (ADMA) as a risk marker for stroke and TIA in a Swedish population.
Wanby P; Teerlink T; Brudin L; Brattström L; Nilsson I; Palmqvist P; Carlsson M
Atherosclerosis; 2006 Apr; 185(2):271-7. PubMed ID: 16055131
[TBL] [Abstract][Full Text] [Related]
2. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
Yoo JH; Lee SC
Atherosclerosis; 2001 Oct; 158(2):425-30. PubMed ID: 11583722
[TBL] [Abstract][Full Text] [Related]
3. [The relationship between serum asymmetric dimethylarginine and ABCD2 score in transient ischemic attack patients].
Zhang Y; Fan D; Zhang N
Zhonghua Nei Ke Za Zhi; 2014 Nov; 53(11):876-9. PubMed ID: 25586358
[TBL] [Abstract][Full Text] [Related]
4. Asymmetric and symmetric dimethylarginine as markers of endothelial dysfunction in cerebrovascular disease: A prospective study.
Bima C; Parasiliti-Caprino M; Rumbolo F; Ponzetto F; Gesmundo I; Nonnato A; Fornengo P; Vaula G; Ghigo E; Mengozzi G; Settanni F
Nutr Metab Cardiovasc Dis; 2024 Jul; 34(7):1639-1648. PubMed ID: 38570234
[TBL] [Abstract][Full Text] [Related]
5. Serum asymmetric dimethylarginine and nitric oxide levels in Turkish patients with acute ischemic stroke.
Ercan M; Mungan S; Güzel I; Celik HT; Bal C; Abusoglu S; Akbulut D; Oguz EF; Yilmaz FM
Adv Clin Exp Med; 2019 May; 28(5):693-698. PubMed ID: 30170483
[TBL] [Abstract][Full Text] [Related]
6. Asymmetric dimethylarginine as a risk marker for early-onset ischemic stroke in Indian population.
Mamatha SN; Nagaraja D; Philip M; Christopher R
Clin Chim Acta; 2011 Jan; 412(1-2):139-42. PubMed ID: 20883678
[TBL] [Abstract][Full Text] [Related]
7. Elevated plasma concentrations of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine predict adverse events in patients undergoing noncardiac surgery.
Maas R; Dentz L; Schwedhelm E; Thoms W; Kuss O; Hiltmeyer N; Haddad M; Klöss T; Standl T; Böger RH
Crit Care Med; 2007 Aug; 35(8):1876-81. PubMed ID: 17581491
[TBL] [Abstract][Full Text] [Related]
8. Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg.
Leong T; Zylberstein D; Graham I; Lissner L; Ward D; Fogarty J; Bengtsson C; Björkelund C; Thelle D;
Arterioscler Thromb Vasc Biol; 2008 May; 28(5):961-7. PubMed ID: 18292394
[TBL] [Abstract][Full Text] [Related]
9. Asymmetric dimethylarginine (ADMA) as a possible risk marker for ischemic stroke.
Nishiyama Y; Ueda M; Katsura K; Otsuka T; Abe A; Nagayama H; Katayama Y
J Neurol Sci; 2010 Mar; 290(1-2):12-5. PubMed ID: 20060545
[TBL] [Abstract][Full Text] [Related]
10. Plasma arginine/ADMA ratio as a sensitive risk marker for atherosclerosis: Shimane CoHRE study.
Notsu Y; Yano S; Shibata H; Nagai A; Nabika T
Atherosclerosis; 2015 Mar; 239(1):61-6. PubMed ID: 25576847
[TBL] [Abstract][Full Text] [Related]
11. Increased concentrations of homocysteine and asymmetric dimethylarginine and decreased concentrations of nitric oxide in the plasma of patients with Alzheimer's disease.
Selley ML
Neurobiol Aging; 2003 Nov; 24(7):903-7. PubMed ID: 12928048
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of asymmetric dimethylarginine and homocysteine in microangiopathy-related cerebral damage.
Notsu Y; Nabika T; Bokura H; Suyama Y; Kobayashi S; Yamaguchi S; Masuda J
Am J Hypertens; 2009 Mar; 22(3):257-62. PubMed ID: 19057516
[TBL] [Abstract][Full Text] [Related]
13. The L-arginine pathway in acute ischemic stroke and severe carotid stenosis: temporal profiles and association with biomarkers and outcome.
Molnar T; Pusch G; Papp V; Feher G; Szapary L; Biri B; Nagy L; Keki S; Illes Z
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2206-2214. PubMed ID: 25018114
[TBL] [Abstract][Full Text] [Related]
14. Asymmetric dimethylarginine as an independent risk marker for mortality in ambulatory patients with peripheral arterial disease.
Böger RH; Endres HG; Schwedhelm E; Darius H; Atzler D; Lüneburg N; von Stritzky B; Maas R; Thiem U; Benndorf RA; Diehm C
J Intern Med; 2011 Mar; 269(3):349-61. PubMed ID: 21175900
[TBL] [Abstract][Full Text] [Related]
15. Asymmetrical dimethylarginine: a novel risk factor for coronary artery disease.
Lu TM; Ding YA; Charng MJ; Lin SJ
Clin Cardiol; 2003 Oct; 26(10):458-64. PubMed ID: 14579916
[TBL] [Abstract][Full Text] [Related]
16. Association between cerebrospinal fluid levels of asymmetric dimethyl-L-arginine, an endogenous inhibitor of endothelial nitric oxide synthase, and cerebral vasospasm in a primate model of subarachnoid hemorrhage.
Jung CS; Iuliano BA; Harvey-White J; Espey MG; Oldfield EH; Pluta RM
J Neurosurg; 2004 Nov; 101(5):836-42. PubMed ID: 15543672
[TBL] [Abstract][Full Text] [Related]
17. The role of L-arginine/L-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients.
Haghikia A; Yanchev GR; Kayacelebi AA; Hanff E; Bledau N; Widera C; Sonnenschein K; Haghikia A; Weissenborn K; Bauersachs J; Bavendiek U; Tsikas D
Amino Acids; 2017 Jun; 49(6):1111-1121. PubMed ID: 28285332
[TBL] [Abstract][Full Text] [Related]
18. Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.
Miyazaki H; Matsuoka H; Cooke JP; Usui M; Ueda S; Okuda S; Imaizumi T
Circulation; 1999 Mar; 99(9):1141-6. PubMed ID: 10069780
[TBL] [Abstract][Full Text] [Related]
19. Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes.
Tarnow L; Hovind P; Teerlink T; Stehouwer CD; Parving HH
Diabetes Care; 2004 Mar; 27(3):765-9. PubMed ID: 14988299
[TBL] [Abstract][Full Text] [Related]
20. Asymmetric dimethyarginine as marker and mediator in ischemic stroke.
Chen S; Li N; Deb-Chatterji M; Dong Q; Kielstein JT; Weissenborn K; Worthmann H
Int J Mol Sci; 2012 Nov; 13(12):15983-6004. PubMed ID: 23443106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
